Skip to main content
. 2021 Feb 24;13(5):932. doi: 10.3390/cancers13050932

Figure 2.

Figure 2

Figure 2

(a): Overall survival as a function of receipt of definitive local therapy vs. none in patients with metastatic sarcoma (log rank p < 0.001). (b): Overall survival as a function of receipt of definitive local therapy in patients with metastatic sarcoma (log rank p < 0.001).